| abstract |
The present invention provides a polymer pegylated < RTI ID = 0.0 > Carbamo mip < / RTI > compound of formula I, and pharmaceutically acceptable salts thereof Equation I Wherein R 1 , R 2 , linker, PEG, n and o are as defined herein. The present invention also provides methods for the manufacture and use of such compounds for the treatment of cancer and in particular for the treatment of malignant tumors of the blood comprising multiple myeloma. |